Your browser doesn't support javascript.
loading
Pharmacological treatment of COVID-19: an opinion paper / Tratamiento farmacológico del COVID-19: un documento de opinión
García-Lledó, Alberto; Gómez-Pavón, Javier; González del Castillo, Juan; Hernández-Sampelayo, Teresa; Martín-Delgado, Mari Cruz; Martín Sánchez, Francisco Javier; Martínez-Sellés, Manuel; Molero García, José María; Moreno Guillén, Santiago; Rodríguez-Artalejo, Fernando.
Afiliação
  • García-Lledó, Alberto; Prince of Asturias Hospital. University of Alcalá. Madrid. España
  • Gómez-Pavón, Javier; Central Hospital of the Red-Cross. Alfonso X el Sabio University. Madrid. España
  • González del Castillo, Juan; San Carlos University Clinical Hospital. Complutense University. Madrid. España
  • Hernández-Sampelayo, Teresa; Gregorio Marañón General University Hospital. Complutense University. Madrid. España
  • Martín-Delgado, Mari Cruz; Torrejón University Hospital. Francisco de Vitoria University. Madrid. España
  • Martín Sánchez, Francisco Javier; San Carlos University Clinical Hospital. Complutense University. Madrid. España
  • Martínez-Sellés, Manuel; Gregorio Marañón General University Hospital. European University. Madrid. España
  • Molero García, José María; Infectious diseases. Family Medicine. Madrid. España
  • Moreno Guillén, Santiago; Ramón y Cajal Hospital. University of Alcalá de Henares. Madrid. España
  • Rodríguez-Artalejo, Fernando; Autonomous Universit. 0Department of Public Health. Madrid. España
Rev. esp. quimioter ; 35(2): 115-130, abr.-mayo 2022. tab
Artigo em Inglês | IBECS | ID: ibc-205323
Biblioteca responsável: ES1.1
Localização: ES15.1 - BNCS
ABSTRACT
The precocity and efficacy of the vaccines developed so far against COVID-19 has been the most significant and saving advance against the pandemic. The development of vaccines has not prevented, during the whole period of the pandemic, the constant search for therapeutic medicines, both among existing drugs with different indications and in the development of new drugs. The Scientific Committee of the COVID-19 of the Illustrious College of Physicians of Madrid wanted to offer an early, simplified and critical approach to these new drugs, to new developments in immunotherapy and to what has been learned from the immune response modulators already known and which have proven effective against the virus, in order to help understand the current situation. (AU)
RESUMEN
La precocidad y la eficacia de las vacunas desarrolladas hasta ahora frente al COVID-19, ha sido el avance más significativo y salvador frente a la pandemia. El desarrollo vacunal no ha impedido, durante todo el periodo de la pandemia, la búsqueda constante de remedios terapéuticos, tanto entre los medicamentos ya existentes y con indicaciones diversas, como en el desarrollo de nuevos fármacos. Sobre estos nuevos fármacos, sobre las novedades en la inmunoterapia y sobre lo aprendido de los moduladores de la respuesta inmune ya conocidos y que se han mostrado eficaces frente al virus, el Comité Científico del COVID-19 del Ilustre Colegio de Médicos de Madrid ha querido ofrecer una aproximación precoz, simplificada y critica que pueda ayudar a comprender la situación actual. (AU)
Assuntos


Texto completo: Disponível Coleções: Bases de dados nacionais / Espanha Base de dados: IBECS Assunto principal: Vacinação em Massa / Infecções por Coronavirus / Pandemias Limite: Humanos Idioma: Inglês Revista: Rev. esp. quimioter Ano de publicação: 2022 Tipo de documento: Artigo Instituição/País de afiliação: Autonomous Universit/España / Central Hospital of the Red-Cross/España / Gregorio Marañón General University Hospital/España / Infectious diseases/España / Prince of Asturias Hospital/España / Ramón y Cajal Hospital/España / San Carlos University Clinical Hospital/España / Torrejón University Hospital/España

Texto completo: Disponível Coleções: Bases de dados nacionais / Espanha Base de dados: IBECS Assunto principal: Vacinação em Massa / Infecções por Coronavirus / Pandemias Limite: Humanos Idioma: Inglês Revista: Rev. esp. quimioter Ano de publicação: 2022 Tipo de documento: Artigo Instituição/País de afiliação: Autonomous Universit/España / Central Hospital of the Red-Cross/España / Gregorio Marañón General University Hospital/España / Infectious diseases/España / Prince of Asturias Hospital/España / Ramón y Cajal Hospital/España / San Carlos University Clinical Hospital/España / Torrejón University Hospital/España
...